Pfizer Corp - נכסים נקיים למניה בודדת PFE

Pfizer Inc. (PFE) relies on an extensive array of proven medications, as evidenced by the book value per share. The current level of 14.86 reflects the state of this parameter amid regulatory pressure and patent expirations. To protect its positions, the behemoth is betting on high-margin oncology, expanding its portfolio through mergers and the release of new innovative vaccines.

The market evaluates Pfizer Inc. (PFE) through the lens of transforming production capacities toward an oncology profile. The book value per share determines the net asset value minus all liabilities, establishing the business's liquidation floor. By analyzing the book value per share trend on GURU.Markets, an investor can see the impact of plant modernization on capital. Growth in this metric confirms the effective repurposing of assets, while a stable figure guarantees fundamental resilience amid market volatility.